Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab Self-Injection in Japanese RA Patients
NCT00603993Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Mar 2006
- Primary completion
- Nov 2006
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of adalimumab in rheumatoid arthritis (RA), sponsored by Abbott Laboratories. Primary endpoint: American College of Rheumatology Criteria Improvement of at Least 20%, 50%, and 70%. Started Mar 2006; status: completed.
02
Drugs
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00603993.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00603993.